AVIRAGEN THERAPEUTICS INC's ticker is AVIR and the CUSIP is 053761102. A total of 44 filers reported holding AVIRAGEN THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $762,000 | -6.8% | 1,344,905 | +12.7% | 0.00% | 0.0% |
| Q3 2017 | $818,000 | +15.5% | 1,193,485 | +12.8% | 0.00% | 0.0% |
| Q2 2017 | $708,000 | +52.3% | 1,058,103 | +48.4% | 0.00% | 0.0% |
| Q1 2017 | $465,000 | -50.2% | 713,005 | -6.1% | 0.00% | 0.0% |
| Q4 2016 | $934,000 | -26.9% | 759,005 | +14.1% | 0.00% | -50.0% |
| Q3 2016 | $1,277,000 | +59.4% | 665,158 | +16.3% | 0.00% | 0.0% |
| Q2 2016 | $801,000 | – | 571,805 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 1,779,976 | $3,417,554,000 | 0.88% |
| Broadfin Capital, LLC | 3,486,711 | $6,694,000 | 0.60% |
| Stonepine Capital Management, LLC | 347,440 | $667,000 | 0.54% |
| TOWERVIEW LLC | 160,000 | $307,000 | 0.14% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 224,477 | $431,000 | 0.05% |
| JW Asset Management, LLC | 8,611 | $17,000 | 0.01% |
| EAGLE GLOBAL ADVISORS LLC | 202,922 | $390,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 204,470 | $393,000 | 0.01% |
| Spark Investment Management LLC | 41,800 | $80,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 89,396 | $172,000 | 0.00% |